Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2001-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1012518831494PMID 11766999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder.

  2000cited by this paper
• Depression in breast cancer patients: the need for treatment.

  1999cited by this paper
• Behavioural toxicity of antianxiety and antidepressant agents

  1999cited by this paper
• Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety.

  1999cited by this paper
• A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer

  1998cited by this paper
• Assessment and treatment of depression in the cancer patient.

  1998cited by this paper
• Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

  1998cited by this paper
• Depression comorbid with medical illness — Treatment with paroxetine

  1998cited by this paper
• Depression in cancer patients: a literature review.

  1998cited by this paper
• A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.

  1997cited by this paper
• Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

  1997cited by this paper
• Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

  1996cited by this paper
• The effect of fluoxetine on anxiety and depression symptoms in cancer patients

  1996cited by this paper
• ANTIDEPRESSANT THERAPY AND BEHAVIOURAL COMPETENCE

  1996cited by this paper
• Pharmacological Treatment of Depression in Cancer Patients

  1996cited by this paper
• Antidepressant therapy and behavioural competence.

  1996cited by this paper
• Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers.

  1995cited by this paper
• Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients.

  1994cited by this paper
• Paroxetine in the Treatment of Chronic Daily Headache

  1994cited by this paper
• Sulpiride and Paroxetine in the Treatment of Chronic Tension‐Type Headache. An Explanatory Double‐Blind Trial

  1994cited by this paper
• Depression and associated anxiety in primary care: A double-blind comparison of paroxetine and amitriptyline

  1993cited by this paper
• [Multicenter double-blind study comparing the efficacy and tolerance of paroxetine and clomipramine in reactive depression in the elderly patient].

  1993cited by this paper
• Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam.

  1993cited by this paper
• The safety profile of paroxetine.

  1992cited by this paper
• A DOUBLE‐BLIND STUDY COMPARISON OF PAROXETINE AND LOFEPRAMINE IN DEPRESSED COMMUNITY PATIENTS

  1992cited by this paper
• Paroxetine in the Treatment of Elderly Depressed Patients in General Practice: A Double‐Blind Comparison with Amitriptyline

  1992cited by this paper
• The safety profile of paroxetine.

  1992cited by this paper
• An overview of studies comparing the efficacy, safety, and tolerability of paroxetine and clomipramine

  1992cited by this paper
• Management of depression in patients with advanced cancer

  1992cited by this paper
• Paroxetine: An Overview of Dosage, Tolerability, and Safety

  1992cited by this paper
• A double blind comparison of paroxetine and loferamine in depressed community patients

  1992cited by this paper
• A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

  1991cited by this paper
• Depression and chronic medical illness.

  1990cited by this paper
• Depression and the cancer patient. Discussion

  1990cited by this paper
• Antidepressants in the Medically Ill: Prediction of Benefits

  1990cited by this paper
• Depression and the cancer patient.

  1990cited by this paper
• Cancer and the mind

  1990cited by this paper
• Relief of Diabetic Neuropathy with Fluoxetine

  1989cited by this paper
• Fluoxetine versus amitriptyline in adult outpatients with major depression

  1989cited by this paper
• The effects of paroxetine and other antidepressants in combination with alcohol on psychomotor activity related to car driving

  1989cited by this paper
• Paroxetine in the treatment of depression: a comparison with imipramine and placebo

  1989cited by this paper
• The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car driving

  1988cited by this paper
• The Safety of Fluoxetine - An Update

  1988cited by this paper
• Psychiatric disorder in a sample of the general population with and without chronic medical conditions.

  1988cited by this paper
• Psychiatric disorder and limitations in physical functioning in a sample of the Los Angeles general population.

  1988cited by this paper
• Treatment of depression in cancer patients

  1985cited by this paper
• A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.

  1985cited by this paper
• Efficacy and safety of mianserin in the treatment of depression of women with cancer

  1985cited by this paper
• The outcome of antidepressant use in the medically ill.

  1985cited by this paper
• Mental attitudes to cancer: an additional prognostic factor.

  1985cited by this paper
• Trimipramine in physical illness with depression.

  1985cited by this paper
• Cancer and the Mind

  1983cited by this paper
• Depression and somatization: a review: Part I

  1982cited by this paper
• Depression and somatization: a review. Part I.

  1982cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• The role antidepressants in hospitalised cancer patients. (A pilot study).

  1978cited by this paper

• Adverse Effects and Safety of Antidepressants and Psychedelics for Depression in Cancer: A Systematic Review of Randomized Controlled Trials

  2025cites this paper
• Epithelial-mesenchymal transition in cancer: A focus on itraconazole, a hedgehog inhibitor.

  2025cites this paper
• Effective maNagement of depression among patients witH cANCEr (ENHANCE): A hybrid systematic review and (attempted) network meta-analysis of randomized controlled trials.

  2025cites this paper
• Behavioral standardization and validation of a new model of cancer-induced depression in sarcoma-bearing mice.

  2025cites this paper
• Psychiatric Considerations in Breast Cancer: an Integrative Review

  2025cites this paper
• Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis

  2025cites this paper
• [Psychopharmacotherapy of mental disorders in hematological patients: security concerns].

  2023cites this paper
• Psychopharmaphobia: Elevated fear of antidepressant medication among patients with major depression and breast cancer.

  2023cites this paper
• Antidepressants for the treatment of depression in people with cancer.

  2023cites this paper
• Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study

  2023cites this paper
• A Recent Review of the Management of Postmenopausal Symptoms in Breast Cancer Survivors

  2023cites this paper
• A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer

  2022cites this paper
• Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment

  2022cites this paper
• Recent trends in the management of depression in persons with cancer

  2021cites this paper
• Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)

  2021cites this paper
• Antidepressant drug use in glioblastoma patients: an epidemiological view.

  2020cites this paper
• Pancreatic Cancer–Associated Depression: A Case Report and Review of the Literature

  2018cites this paper
• Depression and glioblastoma, complicated concomitant diseases: a systemic review of published literature

  2018cites this paper
• A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea

  2018cites this paper
• Antidepressants for the treatment of depression in people with cancer.

  2018cites this paper
• Psychosocial Consequences and Lifestyle Interventions

  2018cites this paper
• Behind the bright headlines, mind the long shadows

  2017cites this paper
• Tratamiento farmacológico de la depresión en cáncer

  2017influential citation
• Impact of depression treatment on health-related quality of life among adults with cancer and depression: a population-level analysis

  2017cites this paper
• Systematic review and meta‐analysis of collaborative care interventions for depression in patients with cancer

  2017cites this paper
• Effect of fluoxetine on quality of life in patients with solid cancers: a double-blind study

  2017cites this paper
• Effect of Citalopram and Aspirin on Hot Flashes and Quality of Life in Premenopausal Women with Breast Cancer: A Randomized Double-blind Clinical Trial

  2016cites this paper
• Management of Depression in Patients With Cancer: A Clinical Practice Guideline.

  2016cites this paper
• Managing Anxiety and Depression During Treatment

  2015cites this paper
• Antidepressants for the treatment of depression in people with cancer.

  2015cites this paper
• A study linking toll-like receptors and irinotecan-induced gastrointestinal mucositis.

  2015cites this paper
• The biology of depression in cancer and the relationship between depression and cancer progression

  2014cites this paper
• Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review

  2014cites this paper
• Chronobiology, cognitive function and depressive symptoms in surgical patients.

  2014cites this paper
• Multiple factors must be considered when selecting the best antidepressant to treat depression in patients with cancer

  2014cites this paper
• BREAST CANCER , CIRCADIAN DISRUPTION , MOOD DISORDERS AND SYMPTOMS CLUSTERS Symptom clusters

  2014cites this paper
• The Effectiveness of Mindfulness Based Art Therapy on Depression, Anxiety, Stress and Quality of Life Among Postmenopausal Women

  2014cites this paper
• Effect of Melatonin on Cognitive Function and Sleep in relation to Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

  2014cites this paper
• Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial

  2014cites this paper
• Information for Physicians and Pharmacists About Drugs That Might Cause Dry Mouth: A Study of Monographs and Published Literature

  2013cites this paper
• Pharmacological treatment of depression in women with breast cancer: a systematic review

  2013influential citation
• Depression in cancer patients

  2013cites this paper
• Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis

  2013cites this paper
• Pharmacological Management of Depression in Patients with Cancer: Practical Considerations

  2013cites this paper
• Treatment of Depression in Patients with Breast Cancer: A Critical Review

  2013cites this paper
• Treatment of depression in adults with cancer: a systematic review of randomized controlled trials

  2013cites this paper
• Repérage et traitement de la dépression en cancérologie

  2013cites this paper
• Multiple factors must be considered when selecting the best antidepressant to treat depression in patients with cancer

  2013cites this paper
• Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case–control study

  2012cites this paper
• Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study

  2012cites this paper
• The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial

  2012cites this paper
• Author ' s response to reviews Title : Antidepressants in the treatment of depression / depressive symptoms in cancer patients : a systematic review and meta-analysis

  2012cites this paper
• The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Substance Use Disorders

  2012cites this paper
• Evidence-based treatment of depression in patients with cancer.

  2012cites this paper
• Paroxetine

  2012cites this paper
• Breast cancer and depression: issues in clinical care

  2012cites this paper
• Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer.

  2012cites this paper
• The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Select Comorbid Medical Conditions

  2012cites this paper
• Epidemiology and management of depression in cancer patients

  2012cites this paper
• The prevalence and pharmacotherapy of depression in cancer patients.

  2011cites this paper
• Análisis del discurso de un grupo de pacientes oncológicos tras el tratamiento de un episodio depresivo un estudio cualitativo

  2011cites this paper
• Psychische Störungen bei somatischen Krankheiten

  2011cites this paper
• Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).

  2011cites this paper
• meta-analyses of safety and efficacy chronic physical health problems: systematic review and Pharmacological interventions for people with depression and

  2011cites this paper
• Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research.

  2011cites this paper
• Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy.

  2011cites this paper
• Duloxetine for the treatment of mood disorder in cancer patients: a 12‐week case‐control clinical trial

  2011cites this paper
• Les antidépresseurs en oncologie : spécificités et particularités

  2010cites this paper
• Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line

  2010influential citation
• Mental problems and psycho-oncological management in cancer treatment

  2010cites this paper
• Women at a dangerous intersection: diagnosis and treatment of depression and related disorders in patients with breast cancer.

  2010cites this paper
• Impact of Depression on Treatment Adherence and Survival from Cancer

  2010cites this paper
• Evidence Based Pharmacotherapy for Depression in Patients with Cancer

  2010cites this paper
• Y25130 hydrochloride, a selective 5HT3 receptor antagonist has potent antimitogenic and apoptotic effect on HT29 colorectal cancer cell line

  2010cites this paper
• [Adverse drug reactions and Alzheimer disease].

  2009cites this paper
• Iatrogénie et maladie d’Alzheimer

  2009cites this paper
• Use of Antidepressants in Patients with Breast Cancer Taking Tamoxifen

  2009cites this paper
• Depressive und Angststörungen bei somatischen Krankheiten

  2009cites this paper
• Chapitre 15 – Traitements psychopharmacologiques

  2008cites this paper
• Clinical Psychopharmacology and Other Somatic Therapies

  2008cites this paper
• [Antidepressants in oncology: issues and clinical perspectives].

  2008cites this paper
• Depression and cancer: recent data on clinical issues, research challenges and treatment approaches

  2008cites this paper
• 34 Psychopharmacology and Other Somatic Therapies

  2008cites this paper
• Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer

  2008cites this paper
• Anxiety disorders and comorbid medical illness.

  2008cites this paper
• Major depression after breast cancer: a review of epidemiology and treatment.

  2008cites this paper
• Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy

  2008influential citation
• The treatment of depression in cancer patients: a systematic review

  2007influential citation
• Treating depression in the medically ill.

  2007cites this paper
• Sertraline effectiveness and safety in depressed oncological patients

  2007cites this paper
• Treatment of depression in cancer patients

  2007cites this paper
• Medical co-morbidity in depressive disorders.

  2007cites this paper
• Quality Indicators for Medication Use in Vulnerable Elders

  2007cites this paper
• Depression Management in Cancer Patients

  2006cites this paper
• A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

  2006cites this paper
• The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin.

  2006cites this paper
• Quality of life, depression, and stress in breast cancer women outpatients receiving active therapy in Taiwan

  2006cites this paper
• Paroxetine for somatic pain associated with physical illness: a review.

  2006cites this paper
• Psycho-oncology: Review and update

  2006cites this paper
• Depression and Stress Reactivity in Metastatic Breast Cancer

  2006cites this paper